Cardiovascular Drugs And Therapy

Cardiovascular Drugs And Therapy英文简介

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.

Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.

Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

Cardiovascular Drugs And Therapy中文简介

《Cardiovascular Drugs And Therapy》是一本由SPRINGER出版商出版的专业医学期刊，该刊创刊于1987年，刊期Bimonthly，该刊已被国际权威数据库SCI、SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：心脏和心血管系统 3区；药学 3区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖心脏和心血管系统等领域，旨在及时、准确、全面地报道国内外心脏和心血管系统工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.947，平均审稿速度平均4.5月。

中科院分区最新升级版（当前数据版本：2021年12月最新升级版）

大类学科	分区	小类学科	分区	Top期刊	综述期刊
医学	3区	CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学	3区 3区	否	否

JCR分区（当前数据版本：2021-2022年最新版）

JCR分区等级	JCR所属学科	分区	影响因子
Q2	PHARMACOLOGY & PHARMACY	Q2	3.947
	CARDIAC & CARDIOVASCULAR SYSTEMS	Q2

期刊指数

影响因子	h-index	Gold OA文章占比	研究类文章占比	OA开放访问	平均审稿速度
3.947	63	23.82%	67.53%	未开放	平均4.5月

IF值(影响因子)趋势图